Superstring Capital Management LP

SEC CIK: 0001931118
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

NBIX holding history

Neurocrine Biosciences Inc in every 13F filed by Superstring Capital Management LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NBIX overview All 13F holders of NBIX Full Q2 2026 holdings

Shares (Q3 2025): 0; Sold out in Q3 2025
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q4 2023

Holdings of NBIX by Superstring Capital Management LP, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q3 2025	0	$0	0.0%	−40,608−100.0%	Sold out	Holders
Q2 2025	40,608	$5.10M	6.4%	+40,608	New	Holders
Q1 2024	0	$0	0.0%	−29,346−100.0%	Sold out	Holders
Q4 2023	29,346	$3.87M	2.8%	–	No prior filing	Holders